He also articulated a very specific doctrine about the role of an FDA commissioner, one that is limited in its power and ...

In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

With multiple stakeholders involved with different interests, the “specialty drug” definition can be a moving target.

Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of ...

There are five projects from Tullamore College. 'Perimenopause Uncovered: Empowering women through knowledge' was entered by ...

Hello, Health Rounds Readers! Today we feature a study that found yet another potential health benefit of GLP-1 drugs, this ...

Kidney and nerve tissue cells can form memories much like brain cells, one new study has found. Another recent study says ...

Generic drugs are incredibly important in the ... such as GLP-1 analogues like liraglutide or semaglutide. Originally, liraglutide and semaglutide are produced at an industrial scale using ...

Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...

"The Republican Party will not cut benefits," Republican House Speaker Mike Johnson said. Also in the news: Medicare drug price negotiations, the House transgender bathroom ban, and more.